Artificial Intelligence in the Genomics Era: A Blessing or a Curse?

Abstract

As it offers tremendous potential for genomic advancements and has become an invaluable tool in understanding and harnessing the power of genetic information, artificial intelligence has revolutionised genomics by enabling researchers to analyse complex genomic data, unravel biological insights, and accelerate discoveries in personalised medicine, disease diagnosis, drug development, and gene editing. Artificial intelligence can be considered both a boon and a bane in the field of genomics, depending on how it is applied and its implications. Artificial intelligence has the potential to bring significant benefits to genomics, including improved data analysis, precision medicine, and drug discovery. However, ethical considerations, interpretability challenges, biases, and the need for human expertise must be carefully addressed to fully harness the potential of artificial intelligence in genomics and ensure its responsible and beneficial application. The purpose of this narrative review is to shed light on the various applications of genomics that take advantage of technological advancements in artificial intelligence, and to identify its benefits and limitations.